|
This report is submitted beyond 30-calendar days from allergan¿s receipt due to the exemption transition period.Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.A review of the device history record has been completed.No deviations or non-conformances noted.Device evaluation: analysis of the returned device identified weight to the spec, crease fold, wear abrasion, deformation.Cloudy and bubbles in the gel observed after autoclave cycle.Based on the device analysis the final assessment is: no issues found related with the manufacturing process.The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.The reason for reoperation: capsular contracture baker grade iii, exchange of textured implant.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.
|